Lyle J Arnold, Biocept's SR VP of R&D and CSO, recently acquired 50,000 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on July 06, 2016. Arnold now owns 60,714 shares of the company. Arnold operates out of San Diego, CA. Some additional info was provided as follows:

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Biocept makes a similar move, sign up!

Other recent filings from the company include the following:

Biocept Announces Pricing Of Public Offering Of Up To 4,925,936 Shares Of Common Stock - Dec. 6, 2017
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Dec. 6, 2017
Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Dec. 6, 2017
General form for registration of securities under the Securities Act of 1933 - Nov. 21, 2017

Auto Refresh

Feedback